fluorodeoxyglucose f18 has been researched along with Adenoma, beta-Cell in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 8 (72.73) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Griffin, L; Kawalilak, L; Walczak, R | 1 |
Dai, M; Jing, F; Liu, Y; Tian, W; Wang, J; Wang, N; Wang, T; Zhang, J; Zhang, Z; Zhao, X | 1 |
Cuccurullo, V; Di Stasio, GD; Mansi, L | 1 |
Chen, J; Cong, L; Cui, Y; Han, J; Luan, Y; Sha, D; Shen, R; Wang, C; Wang, W; Zhang, Z | 1 |
Chevallier, P; Legmann, P; Prat, F; Taieb, D; Tenenbaum, F | 1 |
Barajas, M; Collantes, M; Ecay, M; Escalada, J; Martí-Climent, JM; Peñuelas, I; Quincoces, G; Ramos-Membrive, R; Rodríguez, S | 1 |
Bélissant Benesty, O; Cassou-Mounat, T; Montravers, F; Talbot, JN; Vatier, C | 1 |
Bhattacharya, A; Chakraborty, D; Kamaleshwaran, KK; Manohar, K; Mittal, BR | 1 |
Ansquer, C; Frampas, E; Meurette, G; Pery, C; Regenet, N | 1 |
Brouwers, AH; de Vries, EG; Fiebrich, HB; Hospers, GA; Links, TP; Remkes, WS; Siemerink, EJ | 1 |
Alavi, A; Anderson, GS; Brinkmann, F; Soulen, MC; Zhuang, H | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Adenoma, beta-Cell
Article | Year |
---|---|
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours.
Topics: Animals; Dihydroxyphenylalanine; Dimerization; Edetic Acid; Fluorodeoxyglucose F18; Glucagon-Like Peptide-1 Receptor; Humans; Indium Radioisotopes; Insulinoma; Ligands; Mice; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin | 2019 |
Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions.
Topics: Adenocarcinoma; Cystadenocarcinoma; Cystadenoma; Fluorodeoxyglucose F18; Humans; Insulinoma; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2010 |
9 other study(ies) available for fluorodeoxyglucose f18 and Adenoma, beta-Cell
Article | Year |
---|---|
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography for staging of canine insulinoma: 3 cases (2019-2020).
Topics: Animals; Dog Diseases; Dogs; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Insulinoma; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.
Topics: Congenital Hyperinsulinism; Female; Fluorodeoxyglucose F18; Humans; Insulinoma; Middle Aged; Multiple Endocrine Neoplasia Type 1; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging | 2022 |
Therapeutic effect of sunitinib malate and its influence on blood glucose concentrations in a patient with metastatic insulinoma.
Topics: Aged; Antineoplastic Agents; Blood Glucose; Fluorodeoxyglucose F18; Humans; Indoles; Insulinoma; Liver Neoplasms; Male; Positron-Emission Tomography; Pyrroles; Sunitinib; Tomography, Emission-Computed | 2013 |
Topographic diagnosis: respective roles of morphological and functional imaging.
Topics: 5-Hydroxytryptophan; Anatomy, Cross-Sectional; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemia; Imaging, Three-Dimensional; Insulinoma; Magnetic Resonance Imaging; Pancreatic Neoplasms; Practice Guidelines as Topic; Receptors, Glucagon; Receptors, Somatostatin | 2013 |
Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: is PET imaging of pancreatic beta cell mass feasible?
Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Fluorodeoxyglucose F18; Heterografts; Insulinoma; Male; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2017 |
Tumor Heterogeneity Detected by 68Ga DOTATOC and 18F-FDG PET/CTs in One Malignant Insulinoma With Involvement of the Portal Splenic Confluence and Ovarian Metastases.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Insulinoma; Octreotide; Organometallic Compounds; Ovarian Neoplasms; Pancreatic Neoplasms; Portal Vein; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen | 2016 |
Diffusely increased muscular uptake of [18F]fluorodeoxyglucose: a clue for the diagnosis of insulinoma?
Topics: Adult; Biological Transport; Diffusion; Fluorodeoxyglucose F18; Humans; Insulinoma; Male; Muscle, Skeletal; Radionuclide Imaging | 2010 |
Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Blood Glucose; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Hypoglycemia; Insulin; Insulin Secretion; Insulinoma; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases | 2011 |
FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Transitional Cell; Catheter Ablation; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Insulinoma; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting | 2003 |